Apellis Pharmaceuticals, Inc. (APLS)
18.87
-0.07
(-0.37%)
USD |
NASDAQ |
Mar 16, 16:00
18.80
-0.07
(-0.37%)
Pre-Market: 08:01
Apellis Pharmaceuticals Market Cap : 2.412B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amneal Pharmaceuticals, Inc. | 3.757B |
| Alnylam Pharmaceuticals, Inc. | 42.29B |
| BioMarin Pharmaceutical, Inc. | 11.05B |
| Amicus Therapeutics, Inc. | 4.512B |
| Ionis Pharmaceuticals, Inc. | 11.95B |
Market Cap Related Metrics
| PE Ratio | 152.79 |
| PS Ratio | 2.388 |
| Price to Book Value | 6.517 |
| Price to Free Cash Flow | 53.26 |
| Price | 18.87 |
| Earnings Yield | 0.65% |
| Operating PE Ratio | 43.25 |
| Normalized PE Ratio | 152.79 |